Long Non-coding RNA ZEB1-AS1 Indicates Poor Prognosis and Promotes Melanoma Progression Through Targeting MiR-1224-5p

Overview

Journal Exp Ther Med

Specialty Pathology

Date 2019 Jan 18

PMID 30651872

Citations 17

Authors

Qiong Wang

Ruirui Zhang

Dandan Liu

Affiliations

Soon will be listed here.

Abstract

Long non-coding RNAs (lncRNAs) have critical roles in various types of cancer, but their roles in the development of melanoma and the underlying molecular mechanisms remain to be fully elucidated. In the present study, the role of zinc finger E-box binding homeobox 1 antisense RNA 1 (ZEB1-AS1) in melanoma was assessed. The expression levels of ZEB1-AS1 were increased in melanoma cell lines and tumor tissues as indicated by reverse transcription-quantitative polymerase chain reaction analysis. Kaplan-Meier analysis suggested that higher expression of ZEB1-AS1 predicts poor prognosis of melanoma patients. Furthermore, knockdown of ZEB1-AS1 inhibited the proliferation, migration and invasion of melanoma, suggesting a role of ZEB1-AS1 in the development and progression of melanoma. In addition, a luciferase reporter assay confirmed that the expression of miR-1224-5p was directly regulated by ZEB1-AS1. Transfection with miR-1224-5p mimics reduced the levels of ZEB1-AS1 and the proliferation, migration and invasion of melanoma. In conclusion, ZEB1-AS1 enhances the proliferation, migration and invasion of melanoma, at least in part by inhibiting the expression of miR-1224-5p, and its overexpression is associated with poor survival of melanoma patients. In addition, the ZEB1-AS1/miR-1224-5p interaction may be a promising therapeutic target for melanoma treatment.

Citing Articles

The Role of Non-coding RNAs in Tumorigenesis, Diagnosis/Prognosis, and Therapeutic Strategies for Cutaneous Melanoma.

Schaft N, Dorrie J Methods Mol Biol. 2024; 2883:79-107.

PMID: 39702705 DOI: 10.1007/978-1-0716-4290-0_4.

LncRNAs in melanoma phenotypic plasticity: emerging targets for promising therapies.

Beatriz Cristina Biz T, Carolina de Sousa C, Frank John S, Miriam Galvonas J RNA Biol. 2024; 21(1):81-93.

PMID: 39498940 PMC: 11540095. DOI: 10.1080/15476286.2024.2421672.

Long non-coding RNA GRASLND links melanoma differentiation and interferon-gamma response.

Fischer K, Tiwari S, Thier B, Qiu L, Lin T, Paschen A Front Mol Biosci. 2024; 11:1471100.

PMID: 39398277 PMC: 11466874. DOI: 10.3389/fmolb.2024.1471100.

Microrna-1224-5p Is a Potential Prognostic and Therapeutic Biomarker in Glioblastoma: Integrating Bioinformatics and Clinical Analyses.

Wei X, Zhang Q, Liu C, Wu S, Nong W, Ge Y Curr Med Sci. 2022; 42(3):584-596.

PMID: 35678909 DOI: 10.1007/s11596-022-2593-5.

The Role and Mechanism of microRNA-1224 in Human Cancer.

Ma M, Li J, Zhang Z, Sun J, Liu Z, Zeng Z Front Oncol. 2022; 12:858892.

PMID: 35494023 PMC: 9046935. DOI: 10.3389/fonc.2022.858892.

References

Livak K, Schmittgen T . Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2002; 25(4):402-8. DOI: 10.1006/meth.2001.1262. View

Dalby B, Cates S, Harris A, Ohki E, Tilkins M, Price P . Advanced transfection with Lipofectamine 2000 reagent: primary neurons, siRNA, and high-throughput applications. Methods. 2004; 33(2):95-103. DOI: 10.1016/j.ymeth.2003.11.023. View

Wang J, Dong Y, Wang X, Ma H, Sheng Z, Li G . Expression of EphA1 in gastric carcinomas is associated with metastasis and survival. Oncol Rep. 2010; 24(6):1577-84. DOI: 10.3892/or_00001020. View

Xiao B, Zhu E, Li N, Lu D, Li W, Li B . Increased miR-146a in gastric cancer directly targets SMAD4 and is involved in modulating cell proliferation and apoptosis. Oncol Rep. 2011; 27(2):559-66. DOI: 10.3892/or.2011.1514. View

Qian J, Li R, Wang Y, Shi Y, Luan W, Tao T . MiR-1224-5p acts as a tumor suppressor by targeting CREB1 in malignant gliomas. Mol Cell Biochem. 2015; 403(1-2):33-41. DOI: 10.1007/s11010-015-2334-1. View

Yarmishyn A, Kurochkin I . Long noncoding RNAs: a potential novel class of cancer biomarkers. Front Genet. 2015; 6:145. PMC: 4407501. DOI: 10.3389/fgene.2015.00145. View

Li T, Xie J, Shen C, Cheng D, Shi Y, Wu Z . Upregulation of long noncoding RNA ZEB1-AS1 promotes tumor metastasis and predicts poor prognosis in hepatocellular carcinoma. Oncogene. 2015; 35(12):1575-84. DOI: 10.1038/onc.2015.223. View

Schmidt K, Joyce C, Buquicchio F, Brown A, Ritz J, Distel R . The lncRNA SLNCR1 Mediates Melanoma Invasion through a Conserved SRA1-like Region. Cell Rep. 2016; 15(9):2025-37. PMC: 4889529. DOI: 10.1016/j.celrep.2016.04.018. View

Wei Y, Sun Q, Zhao L, Wu J, Chen X, Wang Y . LncRNA UCA1-miR-507-FOXM1 axis is involved in cell proliferation, invasion and G0/G1 cell cycle arrest in melanoma. Med Oncol. 2016; 33(8):88. DOI: 10.1007/s12032-016-0804-2. View

10.

Lv Q, Hu L, Chen S, Sun B, Fu M, Qin C . A Long Noncoding RNA ZEB1-AS1 Promotes Tumorigenesis and Predicts Poor Prognosis in Glioma. Int J Mol Sci. 2016; 17(9). PMC: 5037710. DOI: 10.3390/ijms17091431. View

11.

Liu C, Lin J . Long noncoding RNA ZEB1-AS1 acts as an oncogene in osteosarcoma by epigenetically activating ZEB1. Am J Transl Res. 2016; 8(10):4095-4105. PMC: 5095304. View

12.

Sun Y, Cheng H, Wang G, Yu G, Zhang D, Wang Y . Deregulation of miR-183 promotes melanoma development via lncRNA MALAT1 regulation and ITGB1 signal activation. Oncotarget. 2016; 8(2):3509-3518. PMC: 5356899. DOI: 10.18632/oncotarget.13862. View

13.

Liu C, Pan C, Cai Y, Wang H . Interplay Between Long Noncoding RNA ZEB1-AS1 and miR-200s Regulates Osteosarcoma Cell Proliferation and Migration. J Cell Biochem. 2017; 118(8):2250-2260. DOI: 10.1002/jcb.25879. View

14.

Liu B, Ye B, Yang L, Zhu X, Huang G, Zhu P . Long noncoding RNA lncKdm2b is required for ILC3 maintenance by initiation of Zfp292 expression. Nat Immunol. 2017; 18(5):499-508. DOI: 10.1038/ni.3712. View

15.

Lin J, Zhan Y, Liu Y, Chen Z, Liang J, Li W . Increased expression of ZEB1-AS1 correlates with higher histopathological grade and promotes tumorigenesis in bladder cancer. Oncotarget. 2017; 8(15):24202-24212. PMC: 5421840. DOI: 10.18632/oncotarget.15527. View

16.

Su W, Xu M, Chen X, Chen N, Gong J, Nie L . Long noncoding RNA ZEB1-AS1 epigenetically regulates the expressions of ZEB1 and downstream molecules in prostate cancer. Mol Cancer. 2017; 16(1):142. PMC: 5568204. DOI: 10.1186/s12943-017-0711-y. View

17.

Yao X, Cui X, Wu X, Xu P, Zhu W, Chen X . Tumor suppressive role of miR-1224-5p in keloid proliferation, apoptosis and invasion via the TGF-β1/Smad3 signaling pathway. Biochem Biophys Res Commun. 2017; 495(1):713-720. DOI: 10.1016/j.bbrc.2017.10.070. View

18.

Zhang L, Zhang L, Guo X, Zhang D, Yang F, Fan Y . Downregulation of miR-335-5p by Long Noncoding RNA ZEB1-AS1 in Gastric Cancer Promotes Tumor Proliferation and Invasion. DNA Cell Biol. 2017; 37(1):46-52. DOI: 10.1089/dna.2017.3926. View

19.

Li J, Li Z, Leng K, Xu Y, Ji D, Huang L . ZEB1-AS1: A crucial cancer-related long non-coding RNA. Cell Prolif. 2017; 51(1). PMC: 6528915. DOI: 10.1111/cpr.12423. View

20.

Liu X, Li S, Li J, Lu H, Yin L, Zheng W . Long non-coding RNA ZEB1-AS1 is associated with poor prognosis in gastric cancer and promotes cancer cell metastasis. Eur Rev Med Pharmacol Sci. 2018; 22(9):2624-2630. DOI: 10.26355/eurrev_201805_14956. View